GENERAL ELECTRIC COMPANY

(GE)
  Report
Delayed Nyse  -  04:00 2022-08-19 pm EDT
77.72 USD   -1.88%
08/19U.S. Air Force Awards $975 Million Contracts to GE, Raytheon, Boeing, Lockheed Martin, Northrop Grumman
DJ
08/17FDA says faulty Philips device reports accelerating as CEO departs
RE
08/17Bernstein Reinstates General Electric at Outperform With $100 Price Target
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

General Electric : GE Healthcare and National Cancer Centre Singapore collaborate on AI-driven research to improve cancer care

06/06/2022 | 11:02pm EDT
  • Collaboration is the first of its kind for GE Healthcare in the Asia-Pacific region.
  • Collaboration will focus on how artificial intelligence (AI) driven research can be used to improve cancer care.

Singapore - 7 June 2022: GE Healthcare today announces a new collaboration with National Cancer Centre Singapore (NCCS), which focuses on how artificial intelligence (AI) driven research can be used to improve cancer care. The collaboration is the first of its kind for GE Healthcare in the Asia-Pacific (APAC) region and aims to spur the potential for more tailored treatment options for specific cancer types and offer the potential to evaluate clinically significant information along the patient journey for a provider's efficient decision making, leveraging on AI and text processing.

In 2020, there were an estimated 19 million new cancer cases in the world, with 9.7 million or 50% of them in the Asia-Pacific, according to Globocan¹. The agreement between GE Healthcare and NCCS will see the two organizations collaborate on new AI-powered solutions for data analytics and clinical workflows that support care for cancer patients in this part of the world-combining GE Healthcare's imaging and monitoring expertise with NCCS's deep expertise in research and development, testing and consultation.

"NCCS is one of the region's leading centres of excellence for cancer research and treatment, and GE Healthcare is committed to supporting them in driving the transformation and advancement of cancer care pathways in Singapore and beyond. This collaboration is an important step forward in our commitment to enabling precision health through digital technology that simplifies healthcare providers' decision-making, accelerates care delivery and has the potential to improve patient outcomes," said Elie Chaillot, President & CEO Intercontinental at GE Healthcare.

"This new collaboration with NCCS is GE Healthcare's first in the Asia-Pacific region that leverages AI-powered research to improve precision health practices for cancer care. Simplifying the way data is managed can help healthcare professionals improve patient outcomes with faster decision making and more precise treatment options," said Dr. Ben Newton, General Manager Oncology at GE Healthcare.

"The National Cancer Centre Singapore continually engages the latest digital innovations to improve the delivery of cancer care for our patients. This collaboration combines the strengths of our clinical perspective and deep expertise in oncology care, analytics and translational research with GE Healthcare's global reach, innovative technologies and services. Working together, we hope to leverage next-generation digital tools to enhance integration of cross-disciplinary information, augment clinical decision making and improve outcomes for our patients," said Associate Professor Iain Tan, Senior Consultant and Director of Research, Division of Medical Oncology, National Cancer Centre Singapore, and Principal Investigator for this collaboration.

The collaboration is the latest in a series of alliances which GE Healthcare has established to support integrated healthcare systems at the local level through improved access to advanced AI technologies and innovations. These include collaborations with SOPHiA GENETICS in the United States and the University of Cambridge and Optellum in the United Kingdom.

- - -

[1] Cancer Today, Global Cancer Observatory 2020 https://gco.iarc.fr/

###

About GE Healthcare:

GE Healthcare is the $17.7 billion healthcare business of GE (NYSE: GE). As a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 48,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world.

Follow us on Facebook, LinkedIn, Twitter, Instagram and Insights for the latest news, or visit our website www.gehealthcare.comfor more information.

Media Contact:

Eileen Tan
[email protected]
+65 9248 1746

business unit tags

Disclaimer

GE - General Electric Company published this content on 06 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 June 2022 03:01:06 UTC.


© Publicnow 2022
All news about GENERAL ELECTRIC COMPANY
08/19U.S. Air Force Awards $975 Million Contracts to GE, Raytheon, Boeing, Lockheed Martin, ..
DJ
08/17FDA says faulty Philips device reports accelerating as CEO departs
RE
08/17Bernstein Reinstates General Electric at Outperform With $100 Price Target
MT
08/15GE Bringing Instrumentation to 'Flex' Hydropower's Muscle
AQ
08/15GE Bringing Instrumentation to "Flex" Hydropower's Muscle
AQ
08/11AMAZON, AND GE FILE JOINT SUIT TO PR : Bloomberg
MT
08/11AFRELEC : Zimbabwe, Zambia sovereign defaults push up cost of $4.5bn Batoka Gorge project
AQ
08/10TINY POWER PLANTS : GE Partners with Sandia Labs to Help Businesses Maximize Their PV Sola..
PU
08/10GE Power Conversion Partners with Sulzer EMS to Deliver 20% Higher Power Capacity with ..
AQ
08/09Ignitis Gamyba Chooses GE Digital's OPM Production Planning Software to Accurately Fore..
BU
More news
Analyst Recommendations on GENERAL ELECTRIC COMPANY
More recommendations
Financials (USD)
Sales 2022 75 159 M - -
Net income 2022 432 M - -
Net Debt 2022 13 451 M - -
P/E ratio 2022 4 197x
Yield 2022 0,50%
Capitalization 85 224 M 85 224 M -
EV / Sales 2022 1,31x
EV / Sales 2023 1,18x
Nbr of Employees 168 000
Free-Float 74,1%
Chart GENERAL ELECTRIC COMPANY
Duration : Period :
General Electric Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENERAL ELECTRIC COMPANY
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Last Close Price 77,72 $
Average target price 89,16 $
Spread / Average Target 14,7%
EPS Revisions
Managers and Directors
H. Lawrence Culp Chairman & Chief Executive Officer
Carolina Dybeck-Happe Chief Financial Officer & Senior Vice President
Victor Abate Chief Technology Officer & Senior Vice President
Nancy Anderson Chief Information Officer & Vice President
Francisco D'Souza Independent Director
Sector and Competitors
1st jan.Capi. (M$)
GENERAL ELECTRIC COMPANY-17.73%85 224
BERKSHIRE HATHAWAY INC.-0.78%655 058
HONEYWELL INTERNATIONAL INC.-3.33%135 789
SIEMENS AG-29.13%86 094
3M COMPANY-18.26%82 738
ILLINOIS TOOL WORKS INC.-12.24%66 166